nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Venoocclusive liver disease—Dactinomycin—ocular cancer	0.0272	0.145	CcSEcCtD
Gemcitabine—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.0224	0.12	CcSEcCtD
Gemcitabine—Recall phenomenon—Dactinomycin—ocular cancer	0.0212	0.113	CcSEcCtD
Gemcitabine—Extravasation—Carboplatin—ocular cancer	0.0114	0.0606	CcSEcCtD
Gemcitabine—Raised liver function tests—Dactinomycin—ocular cancer	0.00797	0.0425	CcSEcCtD
Gemcitabine—Febrile neutropenia—Dactinomycin—ocular cancer	0.00612	0.0326	CcSEcCtD
Gemcitabine—Eruption—Dactinomycin—ocular cancer	0.00598	0.0319	CcSEcCtD
Gemcitabine—Hepatotoxicity—Dactinomycin—ocular cancer	0.00477	0.0254	CcSEcCtD
Gemcitabine—Extravasation—Dactinomycin—ocular cancer	0.00422	0.0225	CcSEcCtD
Gemcitabine—Hypocalcaemia—Dactinomycin—ocular cancer	0.00402	0.0214	CcSEcCtD
Gemcitabine—Ulcer—Dactinomycin—ocular cancer	0.00389	0.0207	CcSEcCtD
Gemcitabine—Infection—Carboplatin—ocular cancer	0.00351	0.0187	CcSEcCtD
Gemcitabine—Sepsis—Dactinomycin—ocular cancer	0.00319	0.017	CcSEcCtD
Gemcitabine—Pain—Carboplatin—ocular cancer	0.00302	0.0161	CcSEcCtD
Gemcitabine—Hepatic failure—Dactinomycin—ocular cancer	0.00297	0.0159	CcSEcCtD
Gemcitabine—Body temperature increased—Carboplatin—ocular cancer	0.00279	0.0149	CcSEcCtD
Gemcitabine—Liver function test abnormal—Dactinomycin—ocular cancer	0.00247	0.0132	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00241	0.0128	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.00241	0.0128	CcSEcCtD
Gemcitabine—Pancytopenia—Dactinomycin—ocular cancer	0.00219	0.0117	CcSEcCtD
Gemcitabine—Neutropenia—Dactinomycin—ocular cancer	0.00216	0.0115	CcSEcCtD
Gemcitabine—Pneumonia—Dactinomycin—ocular cancer	0.00207	0.011	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.00204	0.0109	CcSEcCtD
Gemcitabine—Stomatitis—Dactinomycin—ocular cancer	0.00201	0.0107	CcSEcCtD
Gemcitabine—Agranulocytosis—Dactinomycin—ocular cancer	0.00192	0.0102	CcSEcCtD
Gemcitabine—Pharyngitis—Dactinomycin—ocular cancer	0.00183	0.00978	CcSEcCtD
Gemcitabine—Erythema multiforme—Dactinomycin—ocular cancer	0.00175	0.00932	CcSEcCtD
Gemcitabine—Chills—Dactinomycin—ocular cancer	0.00166	0.00884	CcSEcCtD
Gemcitabine—Alopecia—Dactinomycin—ocular cancer	0.00163	0.00871	CcSEcCtD
Gemcitabine—Erythema—Dactinomycin—ocular cancer	0.00161	0.00858	CcSEcCtD
Gemcitabine—Ill-defined disorder—Dactinomycin—ocular cancer	0.00149	0.00796	CcSEcCtD
Gemcitabine—Anaemia—Dactinomycin—ocular cancer	0.00149	0.00793	CcSEcCtD
Gemcitabine—Malaise—Dactinomycin—ocular cancer	0.00145	0.00774	CcSEcCtD
Gemcitabine—Leukopenia—Dactinomycin—ocular cancer	0.00144	0.00768	CcSEcCtD
Gemcitabine—Myalgia—Dactinomycin—ocular cancer	0.00137	0.0073	CcSEcCtD
Gemcitabine—Discomfort—Dactinomycin—ocular cancer	0.00135	0.00722	CcSEcCtD
Gemcitabine—Oedema—Dactinomycin—ocular cancer	0.00131	0.007	CcSEcCtD
Gemcitabine—Infection—Dactinomycin—ocular cancer	0.0013	0.00696	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dactinomycin—ocular cancer	0.00129	0.00685	CcSEcCtD
Gemcitabine—Anorexia—Dactinomycin—ocular cancer	0.00125	0.00667	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.0012	0.00638	CcSEcCtD
Gemcitabine—Decreased appetite—Dactinomycin—ocular cancer	0.00114	0.00609	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—ocular cancer	0.00113	0.00604	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—ocular cancer	0.00112	0.00599	CcSEcCtD
Gemcitabine—Feeling abnormal—Dactinomycin—ocular cancer	0.00108	0.00577	CcSEcCtD
Gemcitabine—Body temperature increased—Dactinomycin—ocular cancer	0.00104	0.00553	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—ocular cancer	0.000942	0.00502	CcSEcCtD
Gemcitabine—Diarrhoea—Dactinomycin—ocular cancer	0.000898	0.00479	CcSEcCtD
Gemcitabine—Vomiting—Dactinomycin—ocular cancer	0.000835	0.00445	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—ocular cancer	0.000828	0.00441	CcSEcCtD
Gemcitabine—Nausea—Dactinomycin—ocular cancer	0.00078	0.00416	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1B—ocular cancer	0.000364	0.000448	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000363	0.000447	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000363	0.000446	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000363	0.000446	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000363	0.000446	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK6—ocular cancer	0.000362	0.000445	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00036	0.000443	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00036	0.000443	CbGpPWpGaD
Gemcitabine—POLE—S Phase—MYC—ocular cancer	0.000355	0.000437	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—CDKN1A—ocular cancer	0.000349	0.00043	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.000349	0.000429	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000348	0.000429	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000348	0.000428	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000348	0.000428	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND3—ocular cancer	0.000346	0.000426	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSPH—ocular cancer	0.000346	0.000426	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000344	0.000423	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000343	0.000423	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—CDKN1A—ocular cancer	0.000336	0.000414	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000334	0.000411	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND3—ocular cancer	0.000332	0.000408	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CDKN1B—ocular cancer	0.000331	0.000407	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.00033	0.000406	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00033	0.000406	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00033	0.000406	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000329	0.000405	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000325	0.0004	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND2—ocular cancer	0.000324	0.000399	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—HDAC1—ocular cancer	0.000324	0.000399	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000323	0.000398	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000323	0.000398	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—HDAC1—ocular cancer	0.000322	0.000397	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND2—ocular cancer	0.000322	0.000397	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.000322	0.000396	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00032	0.000394	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.000316	0.000389	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000316	0.000389	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CCND1—ocular cancer	0.000315	0.000388	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000315	0.000388	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000312	0.000384	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND2—ocular cancer	0.000311	0.000383	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—HDAC1—ocular cancer	0.000311	0.000383	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000307	0.000378	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CDKN1A—ocular cancer	0.000305	0.000376	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000298	0.000367	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000296	0.000365	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000294	0.000362	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000293	0.00036	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2B—ocular cancer	0.000291	0.000358	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2B—ocular cancer	0.000289	0.000355	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000288	0.000355	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000286	0.000352	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000283	0.000349	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000281	0.000345	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2B—ocular cancer	0.000279	0.000343	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—MYC—ocular cancer	0.000279	0.000343	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000276	0.00034	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000274	0.000337	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.000273	0.000336	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000271	0.000334	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000271	0.000334	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—MYC—ocular cancer	0.000267	0.000329	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—E2F1—ocular cancer	0.000267	0.000328	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GNA11—ocular cancer	0.000266	0.000328	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—E2F1—ocular cancer	0.000265	0.000326	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000263	0.000323	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000259	0.000319	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK6—ocular cancer	0.000258	0.000317	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000257	0.000317	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—E2F1—ocular cancer	0.000256	0.000315	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000256	0.000315	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000255	0.000313	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—ocular cancer	0.000253	0.000311	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000248	0.000305	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000248	0.000305	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GNAQ—ocular cancer	0.000248	0.000305	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK6—ocular cancer	0.000247	0.000304	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000247	0.000304	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000244	0.0003	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000243	0.000299	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000242	0.000297	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000238	0.000292	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000238	0.000292	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.000235	0.00029	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000235	0.000289	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000233	0.000287	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000233	0.000286	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDK2—ocular cancer	0.00023	0.000283	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK2—ocular cancer	0.000229	0.000281	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000225	0.000277	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000223	0.000274	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000222	0.000274	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000222	0.000273	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—HDAC1—ocular cancer	0.000222	0.000273	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND2—ocular cancer	0.000222	0.000273	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK2—ocular cancer	0.000221	0.000272	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000219	0.00027	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDK4—ocular cancer	0.000217	0.000268	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK4—ocular cancer	0.000216	0.000266	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000215	0.000264	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000213	0.000262	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000213	0.000262	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND2—ocular cancer	0.000212	0.000261	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—HDAC1—ocular cancer	0.000212	0.000261	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RB1—ocular cancer	0.000211	0.00026	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RB1—ocular cancer	0.00021	0.000259	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK4—ocular cancer	0.000209	0.000257	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000206	0.000253	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000204	0.000251	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000204	0.000251	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000204	0.000251	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—ocular cancer	0.000203	0.00025	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNA11—ocular cancer	0.000202	0.000248	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2B—ocular cancer	0.000199	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000196	0.000241	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000195	0.000241	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000193	0.000238	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.00019	0.000234	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RB1—ocular cancer	0.000189	0.000233	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RB1—ocular cancer	0.000188	0.000231	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.000188	0.000231	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNAQ—ocular cancer	0.000188	0.000231	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—E2F1—ocular cancer	0.000182	0.000225	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—ocular cancer	0.000181	0.000223	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000178	0.000219	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000178	0.000218	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000176	0.000217	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—E2F1—ocular cancer	0.000175	0.000215	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00017	0.00021	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00017	0.000209	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000169	0.000207	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000166	0.000205	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNA11—ocular cancer	0.000166	0.000205	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNA11—ocular cancer	0.000165	0.000203	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000165	0.000203	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000164	0.000201	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MDM2—ocular cancer	0.000161	0.000198	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MDM2—ocular cancer	0.00016	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000159	0.000196	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000158	0.000194	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK2—ocular cancer	0.000157	0.000194	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000157	0.000193	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000156	0.000192	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000156	0.000192	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNA11—ocular cancer	0.000155	0.000191	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MDM2—ocular cancer	0.000155	0.00019	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNAQ—ocular cancer	0.000154	0.00019	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNAQ—ocular cancer	0.000154	0.000189	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000152	0.000187	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000151	0.000186	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK2—ocular cancer	0.000151	0.000186	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000151	0.000186	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK4—ocular cancer	0.000149	0.000183	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—ocular cancer	0.000147	0.000181	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—ocular cancer	0.000146	0.00018	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000146	0.00018	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000146	0.000179	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—ocular cancer	0.000145	0.000178	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—ocular cancer	0.000145	0.000178	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNAQ—ocular cancer	0.000144	0.000178	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—ocular cancer	0.000144	0.000177	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—ocular cancer	0.000144	0.000177	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK4—ocular cancer	0.000142	0.000175	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—ocular cancer	0.000141	0.000174	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000141	0.000174	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—ocular cancer	0.00014	0.000173	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00014	0.000172	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—ocular cancer	0.00014	0.000172	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—ocular cancer	0.000139	0.000171	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.000139	0.000171	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—ocular cancer	0.000136	0.000167	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000136	0.000167	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—ocular cancer	0.000135	0.000166	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—ocular cancer	0.000135	0.000166	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000134	0.000165	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—ocular cancer	0.00013	0.00016	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—ocular cancer	0.000129	0.000159	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—ocular cancer	0.000129	0.000159	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—ocular cancer	0.000128	0.000158	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—ocular cancer	0.000126	0.000155	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—ocular cancer	0.000125	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000125	0.000153	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—ocular cancer	0.000124	0.000153	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—ocular cancer	0.000124	0.000152	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000123	0.000152	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—ocular cancer	0.000121	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000118	0.000146	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—ocular cancer	0.000113	0.000139	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000113	0.000139	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—ocular cancer	0.000112	0.000138	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MDM2—ocular cancer	0.00011	0.000136	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNA11—ocular cancer	0.000109	0.000134	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—ocular cancer	0.000108	0.000133	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000108	0.000133	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000107	0.000132	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000107	0.000132	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSPH—ocular cancer	0.000107	0.000131	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000106	0.000131	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—ocular cancer	0.000106	0.00013	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000104	0.000128	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000103	0.000127	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000102	0.000125	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNAQ—ocular cancer	0.000101	0.000125	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—ocular cancer	0.000101	0.000124	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	9.95e-05	0.000123	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—ocular cancer	9.89e-05	0.000122	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—ocular cancer	9.64e-05	0.000119	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—ocular cancer	9.6e-05	0.000118	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	9.47e-05	0.000117	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—ocular cancer	9.29e-05	0.000114	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—ocular cancer	9.25e-05	0.000114	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—ocular cancer	9.2e-05	0.000113	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—ocular cancer	9.19e-05	0.000113	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—ocular cancer	8.9e-05	0.00011	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—ocular cancer	8.9e-05	0.000109	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—ocular cancer	8.88e-05	0.000109	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—ocular cancer	8.84e-05	0.000109	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—ocular cancer	8.7e-05	0.000107	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—ocular cancer	8.61e-05	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	8.54e-05	0.000105	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—ocular cancer	8.47e-05	0.000104	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	8.25e-05	0.000102	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—ocular cancer	7.7e-05	9.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	7.53e-05	9.27e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—ocular cancer	7.38e-05	9.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	6.87e-05	8.46e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—ocular cancer	6.74e-05	8.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	6.56e-05	8.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	6.34e-05	7.81e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—ocular cancer	6.33e-05	7.79e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—ocular cancer	6.06e-05	7.46e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	6.04e-05	7.43e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—ocular cancer	5.55e-05	6.83e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—ocular cancer	5.52e-05	6.79e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—ocular cancer	5.38e-05	6.62e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	5.26e-05	6.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	5.25e-05	6.46e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—ocular cancer	5.19e-05	6.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	4.32e-05	5.32e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—ocular cancer	4.07e-05	5.01e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.65e-05	4.49e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—ocular cancer	3.64e-05	4.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNA11—ocular cancer	3.36e-05	4.14e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—ocular cancer	3.36e-05	4.13e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—ocular cancer	3.33e-05	4.1e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—ocular cancer	3.14e-05	3.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNAQ—ocular cancer	3.12e-05	3.84e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—ocular cancer	2.2e-05	2.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—ocular cancer	1.12e-05	1.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—ocular cancer	6.78e-06	8.35e-06	CbGpPWpGaD
